home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Shareware Overload Trio 2
/
Shareware Overload Trio Volume 2 (Chestnut CD-ROM).ISO
/
dir26
/
med9410p.zip
/
M94A3106.TXT
< prev
next >
Wrap
Text File
|
1994-10-25
|
3KB
|
41 lines
Document 3106
DOCN M94A3106
TI HIV infection progression since first pulmonary tuberculosis episode
(PTB).
DT 9412
AU Mandala K; Mukadi YD; Ntikala B; Mayala M; Matela B; Nzila N; Projet
SIDA, Kinshasa, Zaire.
SO Int Conf AIDS. 1994 Aug 7-12;10(1):152 (abstract no. PB0035). Unique
Identifier : AIDSLINE ICA10/94369469
AB OBJECTIVES: To determine the HIV attributable mortality and to
characterize the immunologic evolution of PTB patients since the first
episode onset. To quantify the PTB relapse rate after correct and
specific treatment completion. METHODS: 365 HIV infected TB patients (+
smear sputum) and 203 TB patients were administered a short schema
treatment and followed for 4 years. Fev of HIV(+) TB patients sustained
a six month treatment. During the following, all of them underwent
physical exam and blood count. In case of death, autopsy was performed
when possible. RESULTS: After 6 months of follow-up, 1 (0.5%) HIV(-)
patient died compared to 47 (13.2%) HIV(+) patients among 70% showed (at
the treatment start) a median LT4 absolute number/mm3 < 200. The median
LT4 absolute number/mm3 among HIV(+) TB patients, varied from 317 before
treatment to 451 two months after treatment implantation, decreased to
303 at the end of the treatment and finally grew to 574, six months
after the treatment end. In HIV(-) patients, however, a weak progressive
increase in absolute LT4 number was seen. After three years of
follow-up, a low relapse rate (9.8%) was seen in those of patients who
received an additional treatment, while it was 16.9% in HIV(+) and 12.9%
in seronegatives. CONCLUSIONS: The HIV infection attributable mortality
doesn't seem to be influenced by TB. Correct anti-TB treatment improves
HIV(+) patient immunologic profile; additional treatment seem to delay
the relapse occurrence.
DE AIDS-Related Opportunistic Infections/MORTALITY/*PHYSIOPATHOLOGY
Comparative Study Follow-Up Studies Human HIV
Infections/IMMUNOLOGY/MORTALITY/*PHYSIOPATHOLOGY HIV Seronegativity
HIV Seropositivity/IMMUNOLOGY Recurrence Time Factors Tuberculosis,
Pulmonary/MORTALITY/*PHYSIOPATHOLOGY T4 Lymphocytes MEETING ABSTRACT
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).